Inventor · disambiguated record
Takehito Uruno
Also filed as: URUNO TAKEHITO
6 granted patents·5 pending applications·3 citations·filing 2001–2022
70Inventor score
Top patents by PatentIndex Score
11 records- 0172US10406141B2Pyridinone compound and use thereofUNIV KYUSHU NAT UNIV CORP·Filed 2016·Granted Sep 10, 2019·1 cites·20 claims
- 0265US12213984B2Immunoregulatory agentUNIV KYUSHU NAT UNIV CORP·Filed 2021·Granted Feb 4, 2025·0 cites·9 claims
- 0361US2021337777A1Atopic dermatitis model non-human animal and use thereofUNIV KYUSHU NAT UNIV CORP·Filed 2021·Application pending·0 cites
- 0456US11395826B2Immunoregulatory agentUNIV KYUSHU NAT UNIV CORP·Filed 2016·Granted Jul 26, 2022·0 cites·3 claims
- 0556US2025002526A1Pharmaceutical composition having anti-cancer immunostimulating effect and/or immune checkpoint inhibition potentiating effectUNIV KYUSHU NAT UNIV CORP·Filed 2022·Application pending·0 cites
- 0654US11213020B2Atopic dermatitis model non-human animal and use thereofUNIV KYUSHU NAT UNIV CORP·Filed 2017·Granted Jan 4, 2022·0 cites·2 claims
- 0753US11311523B2Pyridinone compound and use thereofUNIV KYUSHU NAT UNIV CORP·Filed 2019·Granted Apr 26, 2022·0 cites·17 claims
- 0853US7192702B2Modulators of the interaction between Arp2/3 and cortactin or HS-1UNIV MARYLAND·Filed 2001·Granted Mar 20, 2007·2 cites·9 claims
- 0953US2024139214A1Agent for suppressing il-31 production and pharmaceutical composition containing the sameUNIV KYUSHU NAT UNIV CORP·Filed 2022·Application pending·0 cites
- 1049US2022017486A1Dock1-inhibiting compound and use thereofUNIV KYUSHU NAT UNIV CORP·Filed 2019·Application pending·0 cites
- 1147US2021401821A1Prophylactic or therapeutic agent and medicinal composition for il-31-mediated diseaseUNIV KYUSHU NAT UNIV CORP·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Takehito Uruno files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →